upcoming glp-1 drugs New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these at scale. Our What to Make of the
Description
They are usually injectable medications, with a liquid medication injected into the fatty tissue just under your skin

S2CID 249385412

Therefore, this circuit could curb nausea caused by GLP-1R agonism but not interfere with GLP-1 signaling in the NTS, which induces satiety

PROSPERO registration no
Talk to your provider about how to transition off the medication safely if pregnancy is planned
